Ameritas Investment Partners’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$221K Buy
1,948
+137
+8% +$15.6K 0.01% 1235
2025
Q1
$190K Hold
1,811
0.01% 1288
2024
Q4
$194K Buy
1,811
+155
+9% +$16.6K 0.01% 1344
2024
Q3
$166K Hold
1,656
0.01% 1442
2024
Q2
$140K Hold
1,656
﹤0.01% 1510
2024
Q1
$121K Hold
1,656
﹤0.01% 1614
2023
Q4
$118K Hold
1,656
﹤0.01% 1625
2023
Q3
$99.2K Buy
1,656
+279
+20% +$16.7K ﹤0.01% 1662
2023
Q2
$99.3K Buy
1,377
+158
+13% +$11.4K ﹤0.01% 1608
2023
Q1
$89.7K Hold
1,219
﹤0.01% 1607
2022
Q4
$86.7K Sell
1,219
-735
-38% -$52.3K ﹤0.01% 1700
2022
Q3
$104K Hold
1,954
﹤0.01% 1463
2022
Q2
$108K Hold
1,954
﹤0.01% 1451
2022
Q1
$137K Hold
1,954
﹤0.01% 1426
2021
Q4
$188K Hold
1,954
0.01% 1263
2021
Q3
$170K Sell
1,954
-7,324
-79% -$637K 0.01% 1331
2021
Q2
$759K Hold
9,278
0.03% 699
2021
Q1
$882K Buy
9,278
+112
+1% +$10.6K 0.03% 641
2020
Q4
$569K Sell
9,166
-351
-4% -$21.8K 0.03% 734
2020
Q3
$566K Hold
9,517
0.03% 683
2020
Q2
$664K Sell
9,517
-316
-3% -$22K 0.03% 610
2020
Q1
$446K Sell
9,833
-481
-5% -$21.8K 0.03% 661
2019
Q4
$671K Sell
10,314
-771
-7% -$50.2K 0.03% 666
2019
Q3
$688K Sell
11,085
-652
-6% -$40.5K 0.03% 646
2019
Q2
$836K Sell
11,737
-648
-5% -$46.2K 0.04% 582
2019
Q1
$971K Sell
12,385
-469
-4% -$36.8K 0.05% 518
2018
Q4
$1.09M Buy
12,854
+10,058
+360% +$851K 0.06% 420
2018
Q3
$479K Hold
2,796
0.02% 742
2018
Q2
$361K Buy
2,796
+20
+0.7% +$2.58K 0.02% 809
2018
Q1
$286K Sell
2,776
-108
-4% -$11.1K 0.01% 913
2017
Q4
$246K Hold
2,884
0.01% 989
2017
Q3
$231K Hold
2,884
0.01% 981
2017
Q2
$218K Buy
2,884
+247
+9% +$18.7K 0.01% 1016
2017
Q1
$174K Buy
+2,637
New +$174K 0.01% 1136